Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.8M Sell
104,723
-3,838
-4% -$433K 0.13% 116
2025
Q4
$13.7M Sell
108,561
-6,517
-6% -$830K 0.17% 95
2025
Q3
$15.4M Sell
115,078
-2,847
-2% -$374K 0.2% 88
2025
Q2
$16M Buy
117,925
+9,150
+8% +$1.21M 0.22% 83
2025
Q1
$14.4M Sell
108,775
-9,810
-8% -$1.25M 0.22% 86
2024
Q4
$13.4M Buy
118,585
+26,606
+29% +$3.07M 0.19% 95
2024
Q3
$10.4M Sell
91,979
-60
-0.1% -$6.58K 0.15% 105
2024
Q2
$9.5M Buy
92,039
+64,240
+231% +$6.81M 0.16% 94
2024
Q1
$3.16M Buy
27,799
+1,618
+6% +$185K 0.08% 134
2023
Q4
$2.88M Buy
26,181
+3,088
+13% +$309K 0.08% 143
2023
Q3
$2.24M Buy
23,093
+3,050
+15% +$320K 0.08% 131
2023
Q2
$2.19M Sell
20,043
-82
-0.4% -$8.74K 0.07% 144
2023
Q1
$2.04M Buy
20,125
+11,470
+133% +$1.21M 0.07% 150
2022
Q4
$950K Sell
8,655
-104
-1% -$10.8K 0.05% 101
2022
Q3
$847K Buy
8,759
+522
+6% +$55.6K 0.05% 99
2022
Q2
$895K Sell
8,237
-148
-2% -$16.8K 0.05% 98
2022
Q1
$992K Sell
8,385
-654
-7% -$81.1K 0.05% 103
2021
Q4
$1.27M Buy
9,039
+517
+6% +$66.2K 0.06% 82
2021
Q3
$1.01M Buy
8,522
+633
+8% +$77.8K 0.05% 94
2021
Q2
$915K Sell
7,889
-561
-7% -$65.4K 0.05% 99
2021
Q1
$1.01M Sell
8,450
-587
-6% -$69.5K 0.06% 83
2020
Q4
$989K Buy
9,037
+107
+1% +$11.6K 0.07% 79
2020
Q3
$972K Buy
8,930
+1,516
+20% +$154K 0.08% 73
2020
Q2
$678K Sell
7,414
-712
-9% -$64.4K 0.07% 97
2020
Q1
$641K Sell
8,126
-2,209
-21% -$184K 0.08% 96
2019
Q4
$898K Sell
10,335
-374
-3% -$31.3K 0.09% 91
2019
Q3
$896K Sell
10,709
-34
-0.3% -$2.89K 0.1% 86
2019
Q2
$903K Buy
10,743
+60
+0.6% +$4.72K 0.11% 87
2019
Q1
$854K Buy
10,683
+126
+1% +$9.38K 0.1% 88
2018
Q4
$764K Sell
10,557
-85
-0.8% -$5.97K 0.11% 89
2018
Q3
$781K Buy
10,642
+201
+2% +$13.2K 0.1% 96
2018
Q2
$637K Sell
10,441
-1,000
-9% -$60.6K 0.09% 118
2018
Q1
$686K Buy
11,441
+90
+0.8% +$5.42K 0.08% 127
2017
Q4
$648K Sell
11,351
-590
-5% -$32.7K 0.08% 130
2017
Q3
$637K Sell
11,941
-223
-2% -$11.2K 0.08% 125
2017
Q2
$591K Buy
12,164
+306
+3% +$13.9K 0.08% 127
2017
Q1
$527K Buy
11,858
+2,711
+30% +$117K 0.08% 135
2016
Q4
$351K Sell
9,147
-2,352
-20% -$93.3K 0.06% 177
2016
Q3
$486K Sell
11,499
-308
-3% -$13.2K 0.08% 122
2016
Q2
$464K Buy
11,807
+492
+4% +$19.6K 0.09% 113
2016
Q1
$473K Buy
11,315
+1,261
+13% +$50K 0.1% 104
2015
Q4
$452K Buy
10,054
+354
+4% +$15.6K 0.11% 88
2015
Q3
$390K Buy
9,700
+771
+9% +$36.3K 0.1% 93
2015
Q2
$438K Buy
8,929
+146
+2% +$7.01K 0.11% 93
2015
Q1
$407K Buy
8,783
+656
+8% +$30.1K 0.1% 96
2014
Q4
$366K Sell
8,127
-353
-4% -$15.4K 0.1% 100
2014
Q3
$353K Buy
8,480
+311
+4% +$13.2K 0.1% 97
2014
Q2
$334K Buy
8,169
+143
+2% +$5.62K 0.09% 101
2014
Q1
$309K Buy
+8,026
New +$309K 0.09% 105

Other funds holding ABT

Choreo LLC's ABT Position: Q1 2026 in Review

Choreo LLC reduced its Abbott (ABT) stake by 3.5% in Q1 2026, selling an estimated $433K and leaving 104,723 shares worth $10.8M. The position accounts for 0.13% of the portfolio, ranked #116.

Choreo LLC first reported a position in ABT in Q1 2014 and has held it in 49 quarters since. The position peaked at $16M in Q2 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Choreo LLC held 104,723 shares of Abbott worth $10.8M as of Q1 2026.
  • Choreo LLC sold 3,838 Abbott shares in Q1 2026, an estimated $433K.
  • Abbott made up 0.13% of Choreo LLC's portfolio in Q1 2026, its #116 holding.
  • Choreo LLC first reported a position in Abbott in Q1 2014 and has held it in 49 quarters since.
  • Choreo LLC's Abbott position peaked at $16M in Q2 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.